Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Differentiated MSCs in Parkinson's Disease
NCT03684122Phase 2Unknown
- Sponsor
- University of Jordan
- Start
- Jun 2018
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Phase 2, randomised trial in Parkinson's disease (PD) (2 arms), sponsored by University of Jordan. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 6 months. Status: unknown.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03684122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03684122.